Sacubitril/Valsartan as a New Possible Therapeutic Alternative for the Treatment of Hypertension
Anish Desai, Sunaina Anand, Prachi Sanghvi, Aanchal Gvalani & Priyanka Das · Asian Journal of Cardiology Research · 2023
Hypertension, a major modifiable risk factor for cardiovascular disease and global mortality, affects approximately 31.1% of adults worldwide. Resistant hypertension, observed in 13-30% of hypertensive patients, poses a challenge in treatment escalation, contributing to clinical...
Open access
Research Article